Influenza vaccine causes weaker immune response for children of rural Gabon than in semi-urban areasOctober 23, 2007Further influenza research needed on African populations to prepare for pandemic influenza threats Researchers have found that vaccination against influenza strains seem to be more effective in a semi-urban population than in a rural population of schoolchildren in Gabon, Africa, according to an article in the Journal of Infectious Diseases, published by the University of Chicago Press in partnership with the Infectious Diseases Society of America. The study is one of eight that will be presented and webcast live from the National Institutes of Health on October 22, 2007 as part of the launch of the Council of Science Editors' Global Theme Issue on Poverty and Human Development. The live stream is available beginning at 10 a.m. ET at: http://videocast.nih.gov/summary.asp?live=6239.
Lead author E. van Riet (Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands) and a team of researchers analyzed antibody and cellular responses to influenza A and B strains in 33 children from a semi-urban school in Lambaréné in Gabon, Africa, and 22 children from a rural area nearby. The group found that H1N1, H3N2 and B influenza virus-specific antibodies were already present in the majority of sera before vaccination indicating that influenza strains have already been circulating in Gabon. With little information available about influenza in Africa, the findings of this study indicate that the presence of the virus has probably been underestimated. Children in the two areas differed with respect to the rates of parasitic infections (higher in rural areas), as well as nutritional status (poorer in rural areas). Following vaccination, influenza virus HI antibody titers increased in both the rural and the semi-urban schoolchildren, but reached significantly higher levels in the semi-urban schoolchildren. The highest titers were seen in semi-urban children not infected with helminths. Influenza specific IL-10, TNF-alfa, and IFN-gamma responses were higher in the semi-urban children, whereas IL-5 responses were higher in the rural children , indicating a skewing toward Th2 responses in the rural children may, at least partly, be the result of the immune-modulating effects of helminths," says van Riet. These studies indicate for the first time that influenza virus infections are frequent in Gabon, and suggest that many cases of febrile illness incorrectly diagnosed and mistreated as malaria may actually be due to influenza. In addition, these studies suggest that influenza vaccination will be less effective in rural children than in their semi-urban counterparts, likely because of co-infection with parasites and/or poor nutrition. Closer attention to nutrition and concomitant infections may profoundly affect responses to pandemic influenza and influenza vaccines in developing countries. "With the current attention to the pandemic threat of avian influenza viruses, its global spread, and the preparation of preventive and curative vaccines, it is important to start asking what the immunological consequences of influenza vaccine are in African populations," says van Riet. The researchers noted that epidemiological data on influenza, as well as on immune responses to vaccination, will be critical for proper management of influenza epidemics in Africa. In addition, improving diagnoses of influenza, and distinguishing it from diseases with similar symptoms such as malaria, will have important implications for medication dosages. University of Chicago Press Journals | |||||||||||||||||||||
|
Related Influenza Current Events and Influenza News Articles Avian flu becoming more resistant to antiviral drugs, says University of Colorado study A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested. Genetic mutation causes familial susceptibility for degenerative brain disease Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center - the nucleus - puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE). Scientists isolate genes that made 1918 flu lethal By mixing and matching a contemporary flu virus with the "Spanish flu" - a virus that killed between 20 and 50 million people 90 years ago in history's most devastating outbreak of infectious disease - researchers have identified a set of three genes that helped underpin the extraordinary virulence of the 1918 virus. Using math to understand hep. C: Patterns paint picture of who will respond to treatment Genetic patterns are like the tea leaves in the bottom of a cup for predicting which patients are likely to respond to medical therapy for life-threatening viruses such as hepatitis C, Saint Louis University researchers have discovered. Study first to show that RNA interference can facilitate vaccine development Pharmaceutical companies and universities are racing to develop drugs that use the gene silencing mechanism known as RNA interference to treat a host of diseases. Researchers recreate SARS virus, open door for potential defenses against future strains Researchers at the University of North Carolina at Chapel Hill and Vanderbilt University Medical Center have synthetically reconstructed the bat variant of the SARS coronavirus (CoV) that caused the SARS epidemic of 2003. Study of ancient and modern plagues finds common features In 430 B.C., a new and deadly disease-its cause remains a mystery-swept into Athens. The walled Greek city-state was teeming with citizens, soldiers and refugees of the war then raging between Athens and Sparta. Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. More Influenza Current Events and Influenza News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||